Santen Pharmaceutical Co., Ltd.

OTCPK:SNPH.Y Stock Report

Market Cap: US$4.3b

Santen Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SNPH.Y?
Owner TypeNumber of SharesOwnership Percentage
Institutions155,855,21048.5%
General Public165,823,63151.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 45.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.81%
Silchester International Investors LLP
31,560,500US$426.1m0%1.63%
5.68%
BlackRock, Inc.
18,276,377US$246.8m2.11%no data
4.27%
Black Creek Investment Management Inc.
13,738,444US$185.5m0%2.7%
4.03%
Nomura Asset Management Co., Ltd.
12,979,500US$175.2m-0.32%0.04%
3%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
9,662,560US$130.5m0%0.06%
2.89%
Amova Asset Management Co., Ltd.
9,290,000US$125.4m0%0.03%
2.83%
Vanguard Capital Management, LLC
9,102,876US$122.9m0.38%no data
2.74%
Norges Bank Investment Management
8,800,543US$118.8m0%0.01%
1.55%
Daiwa Asset Management Co., Ltd.
4,999,600US$67.5m0%0.03%
1.05%
Dimensional Fund Advisors LP
3,391,087US$45.8m21.6%0.01%
1%
FMR LLC
3,213,726US$43.4m-1.24%no data
0.93%
Canada Pension Plan Investment Board
2,993,000US$40.4m0%0.02%
0.86%
Vanguard Fiduciary Trust Company
2,776,762US$37.5m0.51%no data
0.72%
Mitsubishi UFJ Asset Management Co., Ltd.
2,321,100US$31.3m2.49%0.01%
0.59%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,904,600US$25.7m1.13%no data
0.59%
Bessemer Investment Management LLC
1,881,972US$25.4m0.04%0.03%
0.44%
BNY Asset Management
1,413,300US$19.1m0.23%no data
0.4%
Arbejdsmarkedets Tillægspension (Atp)
1,292,900US$17.5m0%0.09%
0.39%
Asset Management One Co., Ltd.
1,250,900US$16.9m-3.57%0.01%
0.38%
Victory Capital Management Inc.
1,229,200US$16.6m-0.03%0.01%
0.36%
Charles Schwab Investment Management, Inc.
1,146,980US$15.5m-2.95%no data
0.32%
Vanguard Asset Management, Limited
1,042,422US$14.1m0.73%no data
0.29%
Goldman Sachs Asset Management, L.P.
929,497US$12.5m-31.2%no data
0.29%
Sumitomo Mitsui DS Asset Management Company, Limited
925,300US$12.5m9.31%0.02%
0.25%
State Street Global Advisors, Inc.
816,700US$11.0m-0.05%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/02 17:54
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Santen Pharmaceutical Co., Ltd. is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Koichi MameganoBofA Global Research
Hidemaru YamaguchiCitigroup Inc